Systematic review of lung clearance index (LCI) in non-cystic fibrosis (CF), non-primary ciliary dyskinesia (PCD) bronchiectasis (Bx)

C. Hine (Birmingham, United Kingdom), M. Desai (Birmingham, United Kingdom), J. Davies (London, United Kingdom), E. Sapey (Birmingham, United Kingdom), P. Nagakumar (Birmingham, United Kingdom)

Source: Virtual Congress 2021 – Bronchiectasis
Session: Bronchiectasis
Session type: E-poster
Number: 2073

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Hine (Birmingham, United Kingdom), M. Desai (Birmingham, United Kingdom), J. Davies (London, United Kingdom), E. Sapey (Birmingham, United Kingdom), P. Nagakumar (Birmingham, United Kingdom). Systematic review of lung clearance index (LCI) in non-cystic fibrosis (CF), non-primary ciliary dyskinesia (PCD) bronchiectasis (Bx). 2073

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Bacterial biofilms in bronchiectasis of primary ciliary dyskinesia (PCD) in comparison with cystic fibrosis (CF)
Source: Annual Congress 2012 - Prognostic indices in respiratory infections
Year: 2012

Lung clearance index (LCI) and hyperinflation in children with cystic fibrosis (CF)
Source: Annual Congress 2012 - Cystic fibrosis (adults and children): new basic and clinical physiology research
Year: 2012


Monitoring small airways disease (SAD) in cystic fibrosis (CF)
Source: Annual Congress 2011 - Monitoring with lung function tests in airway diseases
Year: 2011


Variability of the lung clearance index (LCI) assessed pre and post physiotherapy in patients with cystic fibrosis (CF)
Source: Annual Congress 2008 - Clinical applications of ventilatory function tests in paediatric pulmonology
Year: 2008

Relationship between nasal potential difference (NPD) and respiratory function in cystic fibrosis (CF) patients
Source: Eur Respir J 2001; 18: Suppl. 33, 125s
Year: 2001

Lung clearance index (LCI) and trapped gas (TG) may reflect different aspects of Cystic Fibrosis (CF) lung disease in infants
Source: Eur Respir J 2003; 22: Suppl. 45, 228s
Year: 2003

Disease expression in patients with primary ciliary dyskinesia (PCD), CF and pancreatic sufficiency (CF-PS) and insufficiency (CF-PI)
Source: Annual Congress 2011 - Mechanism and monitoring of airway diseases
Year: 2011

The potential of closed circuit lung clearance index (LCI) to provide longitudinal clinical utility in cystic fibrosis (CF).
Source: International Congress 2019 – Physiology of cystic fibrosis
Year: 2019


Dual release ciprofloxacin for inhalation (DRCFI) reduces sputum pseudomonas aeruginosa (Pa) density and delays time to infective pulmonary exacerbation in non-cystic fibrosis (CF) bronchiectasis (BE)
Source: Annual Congress 2011 - Advances in antibiotic therapy of non-cystic fibrosis bronchiectasis
Year: 2011


Differences in airway inflammation between children with primary ciliary dyskinesia (PCD) and cystic fibrosis (CF)
Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology
Year: 2014

Enhanced apoptosis of alveolar lymphocytes (AL), but not macrophages (AM) in interstitial idiopathic pneumonias (IIPs). Special attention to idiopathic pulmonary fibrosis (IPF) results
Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease
Year: 2010

Preschool lung clearance index (LCI) predicts adolescent lung function in cystic fibrosis (CF)
Source: International Congress 2015 – Cystic fibrosis: physiology, biomarkers, microbiology and miscellaneous
Year: 2015


Comparison of ventilation heterogeneity (VH) measured with multiple breath washout (MBW) imaging to whole lung MBW LCI and FEV1 in asthma and cystic fibrosis (CF)
Source: International Congress 2015 – Functional imaging approaches for evaluating alteration of lung, airways and respiratory muscles
Year: 2015


Safety of sputum induction (SI) in interstitial lung disease (ILD)
Source: Annual Congress 2007 - Clinical aspects of interstitial lung disease
Year: 2007


Outcome differences between idiopathic pulmonary fibrosis (IPF) and other interstitial lung diseases (ILD) - data from the EXCITING registry
Source: International Congress 2018 – The world of idiopathic pulmonary fibrosis (IPF): global registries
Year: 2018



Breathing pattern during rest and exercise in patients with cystic fibrosis (CF), pulmonary fibrosis (PF) and COPD before lung transplantation
Source: Eur Respir J 2005; 26: Suppl. 49, 685s
Year: 2005

Intestinal current measurement (ICM) as a new diagnostic test for cystic fibrosis (CF)
Source: Annual Congress 2011 - Cystic fibrosis: New aspects of diagnosis, inflammation and detecting exacerbation
Year: 2011

Macrolides in cystic fibrosis (CF); clinical experience
Source: Eur Respir J 2004; 24: Suppl. 48, 615s
Year: 2004

Daily tele-monitoring of symptoms and spirometry in chronic obstructive pulmonary disease (COPD) and cystic fibrosis (CF) – A comparative study
Source: Annual Congress 2010 - COPD: diagnosis
Year: 2010

Alveolar lymphocytes (AL) apoptosis in interstitial lung diseases (ILD). Increased AL apoptosis rate in idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2009 - Pathogenesis of pulmonary fibrosis
Year: 2009